What is Pison?
Founded in 2016, Pison Technology operates at the intersection of neuroscience and technology, developing an insights platform that leverages biopotential data. This innovative approach supports advancements in critical sectors including medicine, sports performance enhancement, and general wellness. Pison's technology aims to provide novel ways for individuals and systems to interact with both the physical and digital realms by interpreting neurological signals.
How much funding has Pison raised?
Pison has raised a total of $7M across 1 funding round:
Series A
$7M
Series A (2021): $7M with participation from Lavrock Ventures LLC
Key Investors in Pison
Lavrock Ventures LLC
Lavrock Ventures LLC is an investment firm that likely focuses on technology and innovation, potentially supporting companies with disruptive applications in areas such as Pison's biopotential technology.
What's next for Pison?
With the recent major strategic investment and the overall enterprise-level capital secured, Pison is poised for significant expansion and product development. The company's focus on neurological insights positions it to capitalize on growing markets in health tech, wearable technology, and personalized wellness solutions. Future endeavors will likely involve scaling its platform, forging new partnerships, and further validating its applications in medicine and sports performance, driving deeper integration of its biopotential technology into everyday life.
See full Pison company page
